The Effect of Rituximab on the Humoral Response to Influenza Vaccine
Clinical trial NCT00466037 · TERMINATED
Trial details
- NCT number
- NCT00466037
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.